Predicts 2025: CIOs Prepare for AI to Reshape Life Sciences

This Gartner® report reveals how Artificial Intelligence (AI) and Generative AI (GenAI) are transforming the life sciences industry, unpacking the key challenges CIOs foresee and the organisational changes required to turn bold ambitions into scalable, successful outcomes. 

AI (and particularly GenAI) is already transforming the Life Sciences industry. For example, the introduction of synthetic data and digital twins has hugely accelerated research and discovery, changing the approach to patient care. 

Recent approaches, like modular content, are already being surpassed. Organisations that are explore what’s coming next and proactively implementing AI technology will be poised to lead, while those that hesitate risk falling behind. 

Success depends as much on cultural alignment and governance as it does on technology itself. CIOs must change the way they lead, moving beyond simply focusing on new technology to rethinking how people, processes and cross-functional collaborations deliver measurable business outcomes. 

We understand that this report explores: 

• The people and process-related reasons why AI projects fail, and strategies for CIOs to mitigate these risks. 

• The value that new technologies (like synthetic data and digital twins) bring to simulate clinical trials, drug discovery and commercial operations, while maintaining data privacy. 

• How AI can revolutionise content development in Life Sciences, driving better productivity and personalisation. 

• Why culture change is essential for return on investment on GenAI investments – and how to set up for success from the start. 

• The importance of strategic planning and cross-functional governance to assess risk and scale AI initiatives effectively.